Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022.
Amy Ying Xin YuPeter C AustinCynthia A JackeviciusAnna ChuJessalyn K HolodinskyMichael D HillNoreen KamalMukesh KumarDouglas S LeeManav V VyasRaed A JoundiNadia A KhanMoira K KapralCandace D McNaughtonPublished in: Journal of the American Heart Association (2024)
Population-level increases in new antihyperglycemic and antihypertensive prescriptions during the pandemic reversed prepandemic declines and were sustained for >2 years. Our findings are concerning for current and future cardiovascular health.